Back to top
more

Option Care Health (OPCH)

(Real Time Quote from BATS)

$28.05 USD

28.05
18,029

-0.05 (-0.18%)

Updated Aug 6, 2025 09:52 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Best Growth Stocks to Buy for August 30th

by Zacks Equity Research

BEKE, CWCO and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 30, 2023.

Zacks Equity Research

Best Growth Stocks to Buy for August 28th

by Zacks Equity Research

FC, CWCO and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 28, 2023.

Zacks Equity Research

Best Growth Stocks to Buy for August 25th

by Zacks Equity Research

OPCH, STRL and FC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 25, 2023.

Zacks Equity Research

Option Care (OPCH) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

Option Care (OPCH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Zacks Equity Research

Best Growth Stocks to Buy for August 23rd

by Zacks Equity Research

OPCH, STRL and FC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 23, 2023.

Zacks Equity Research

Best Growth Stocks to Buy for August 21st

by Zacks Equity Research

OPCH, TEX and FC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 21, 2023.

Zacks Equity Research

Best Growth Stocks to Buy for August 18th

by Zacks Equity Research

FOUR, PCRFY and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 18, 2023.

Zacks Equity Research

Best Growth Stocks to Buy for August 17th

by Zacks Equity Research

GO, OPCH and NJDCY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 17, 2023.

Zacks Equity Research

OPCH vs. CHE: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

OPCH vs. CHE: Which Stock Is the Better Value Option?

Zacks Equity Research

Best Growth Stocks to Buy for August 15th

by Zacks Equity Research

STRL, OPCH and NJDCY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 15, 2023.

Zacks Equity Research

Best Growth Stocks to Buy for August 11th

by Zacks Equity Research

OPCH, PCRFY and BEKE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 11, 2023.

Zacks Equity Research

Why Option Care (OPCH) Might be Well Poised for a Surge

by Zacks Equity Research

Option Care (OPCH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

Best Growth Stocks to Buy for August 4th

by Zacks Equity Research

TOL, CWCO and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2023.

Zacks Equity Research

Zacks.com featured highlights include Mr. Cooper Group, Masco, Option Care Health, Solaris Oilfield Infrastructure, PulteGroup

by Zacks Equity Research

Mr. Cooper Group, Masco, Option Care Health, Solaris Oilfield Infrastructure, PulteGroup are part of the Zacks Screen of the Week article.

Nilanjan Choudhury headshot

Time to Add These 5 Relative Price Strength Stocks

by Nilanjan Choudhury

COOP, MAS, OPCH, SOI and PHM are five stocks with explosive relative price strength.

Zacks Equity Research

Option Care (OPCH) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Option Care (OPCH) delivered earnings and revenue surprises of 186.36% and 0.39%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

OPCH or USPH: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

OPCH vs. USPH: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why Momentum in Option Care (OPCH) Should Keep going

by Zacks Equity Research

Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Equity Research

Option Care (OPCH) Moves 5.2% Higher: Will This Strength Last?

by Zacks Equity Research

Option Care (OPCH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Option Care (OPCH) Surges 6.3%: Is This an Indication of Further Gains?

by Zacks Equity Research

Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Option Care (OPCH) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Option Care (OPCH) delivered earnings and revenue surprises of 23.53% and 1.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Amedisys (AMED) Q1 Earnings Top Estimates

by Zacks Equity Research

Amedisys (AMED) delivered earnings and revenue surprises of 16.28% and 0.58%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate ATI Physical Therapy, Inc. (ATIP) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

ATI Physical Therapy, Inc. (ATIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Option Care (OPCH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Universal Health (UHS) to Release Q1 Earnings: Factors to Note

by Zacks Equity Research

Universal Health's (UHS) Q1 results are likely to benefit from higher patient volumes and solid demand for behavioral healthcare services. However, increased labor costs might partly offset the results.